Cmin for MR-formulations? [Regulatives / Guidelines]

posted by Marcel – 2010-04-23 12:09 (5894 d 14:32 ago) – Posting: # 5196
Views: 26,308

❝ The MR guidance is a little bit outdated (1999) - and you may expect that regulators are quite aware about recent developments. The current workprogramme of EMA's EWP states that a revision of CPMP/EWP/280/96 is to be considered in 2010.


Is this still the case? I'm looking through the current work programme for 2010 and can't find anything on this in it. If this is still the case, in your opinion can we expect a draft guidance out in 2010?

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
152 visitors (0 registered, 152 guests [including 59 identified bots]).
Forum time: 02:41 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5